Cite
Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease.
MLA
Tincopa, Monica A., and Rohit Loomba. “Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease.” Seminars in Liver Disease, vol. 44, no. 3, Aug. 2024, pp. 287–99. EBSCOhost, https://doi.org/10.1055/s-0044-1788277.
APA
Tincopa, M. A., & Loomba, R. (2024). Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease. Seminars in Liver Disease, 44(3), 287–299. https://doi.org/10.1055/s-0044-1788277
Chicago
Tincopa, Monica A., and Rohit Loomba. 2024. “Noninvasive Tests to Assess Fibrosis and Disease Severity in Metabolic Dysfunction-Associated Steatotic Liver Disease.” Seminars in Liver Disease 44 (3): 287–99. doi:10.1055/s-0044-1788277.